PepScribe

How-to guide · GLP-1

How to get a weight loss injection. - Reddit

Last updated July 1, 2026

More: Clinical standards · Pharmacy partners

Getting a weight loss injection — semaglutide, tirzepatide, or another clinician-prescribed GLP-1 medication — requires a valid prescription. This article explains the step-by-step process for how to get a weight loss injection through a telehealth provider, what eligibility looks like, what the prescription covers, and what to expect once medication arrives.

Quick answer

To get a weight loss injection legally in the USA, you need a prescription from a licensed clinician. Eligibility is typically based on a BMI of 30 or higher (or 27 or higher with a weight-related condition like hypertension or type 2 diabetes). A telehealth provider handles the intake, clinical review, and prescription — which is then filled by a licensed 503A compounding pharmacy in the USA and shipped to you.

Compounded semaglutide and tirzepatide are the most commonly prescribed options. They are not FDA-approved as finished drug products, but they are prepared under a valid prescription by licensed 503Apharmacies operating under USP quality standards — not gray-market or overseas vendors.

Key takeaways

  • A weight loss injection requires a prescription from a licensed clinician — you cannot legally buy semaglutide or tirzepatide without one.
  • Eligibility typically requires a BMI of 30+, or 27+ with a weight-related condition like hypertension, type 2 diabetes, or sleep apnea.
  • Semaglutide (GLP-1) and tirzepatide (dual GIP/GLP-1) are the most common compounded options, dispensed by licensed USA 503A pharmacies and self-administered as a weekly subcutaneous injection.
  • Branded GLP-1 medications can cost $1,000+ per month without insurance; compounded versions are generally substantially lower.
  • Compounded semaglutide and tirzepatide are not FDA-approvedas finished products; “research chemical” vials sold without a prescription have no sterility or purity testing and are genuinely dangerous.

Wondering if you qualify for a weight loss injection? A licensed clinician reviews your intake and prescribes only if it’s appropriate.

Check your eligibility

Step 1: What does the clinical intake cover?

Every legitimate weight loss injection starts with a clinical evaluation. You cannot purchase semaglutide or tirzepatide without a prescription, and no reputable provider issues prescriptions without first reviewing your health history.

A clinical intake typically covers:

  • Current height and weight (to calculate BMI)
  • Primary health goals and weight history
  • Relevant medical history: thyroid disorders, pancreatitis, gallbladder disease, kidney disease, heart conditions
  • Current medications and supplements (for interaction screening)
  • Contraindications: personal or family history of medullary thyroid carcinoma or MEN2 syndrome
  • Pregnancy or breastfeeding status

Telehealth platforms allow this intake to happen online, typically through a structured questionnaire. You do not need an in-person office visit in most states.

Step 2: How does a clinician determine eligibility for weight loss injections?

A licensed clinician — physician, nurse practitioner, or physician assistant, depending on the platform and your state — reviews your intake. This is a real clinical review, not automated approval.

Standard prescribing guidelines for GLP-1 medications indicate eligibility at:

  • BMI ≥ 30 (obesity), regardless of other conditions
  • BMI ≥ 27 with at least one weight-related comorbidity: hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease

The clinician may also consider your goals, whether you have tried other weight management approaches, and whether any contraindications apply. If the medication is not appropriate for you, a good clinician will tell you that rather than issue an inappropriate prescription.

Step 3: Why does the prescription go to a licensed 503A pharmacy?

Once approved, your clinician sends the prescription to a licensed compounding pharmacy. For compounded weight management medications, these are 503A pharmacies located in the USA — not overseas suppliers, not unregulated peptide vendors.

The medication compounded at a licensed 503A pharmacy contains the same active pharmaceutical ingredient as the branded products. Compounded preparations are not FDA-approved as finished drug products, but they are dispensed under a valid prescription and prepared under USP quality standards.

No hidden overseas supply chain. No gray-market peptide suppliers. The pharmacy ships directly to your address with cold-chain packaging as required.

A weight loss injection from a licensed 503A pharmacy under a valid prescription is not the same product as an unlabeled vial bought online.

Step 4: How does self-administration at home work?

Semaglutide and tirzepatide are both administered as weekly subcutaneous injections — meaning a small needle inserted just under the skin, typically in the abdomen, thigh, or upper arm. The needle is short-gauge and the injection volume is small; most patients describe the injection as minimal discomfort after the first few weeks.

Your prescribing clinician or pharmacy will provide administration instructions. Key points:

  • Inject on the same day each week
  • Rotate injection sites to reduce tissue irritation
  • Start at the lowest prescribed dose and escalate as directed
  • Store medication refrigerated (36°F–46°F); never freeze
  • Inspect the solution before each injection — it should be clear and colorless to slightly yellow

Step 5: What do ongoing check-ins and dose management involve?

Weight management with GLP-1 medications is not a one-time prescription and done. Dose escalation typically occurs over months, moving from a starting dose up to a maintenance dose based on tolerability and response. Your clinician monitors this progression.

Regular check-ins allow the clinician to:

  • Adjust the dose upward when you are tolerating the current level
  • Address side effects — especially GI symptoms during dose escalation
  • Monitor for any signs of complications
  • Evaluate whether the medication continues to be appropriate as your weight and health profile change

Most patients on GLP-1 therapy see meaningful weight loss accumulate over 6–12 months of consistent use. Stopping the medication typically reverses weight loss over time, which is why long-term management planning matters.

Which weight loss injection is right for you?

The two most commonly prescribed compounded weight loss injections are semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 receptor agonist). Both drive weight loss through appetite reduction and caloric intake suppression.

Clinical trials show tirzepatide produces somewhat greater average weight loss than semaglutide, though individual responses vary. Your clinician will discuss which option fits your health history, any contraindications, and your goals. Neither is appropriate for everyone — that determination belongs to a prescribing clinician, not a website.

Other injectable options exist (liraglutide, for example), but compounded semaglutide and tirzepatide dominate the current telehealth landscape for weight management due to their evidence base and once-weekly dosing convenience.

What should you avoid when looking for weight loss injections?

The internet hosts a significant market of unregulated vendors selling "research chemical" semaglutide and tirzepatide, often labeled "not for human use" to avoid FDA scrutiny. These products are not manufactured to pharmaceutical standards, have no sterility testing, and have no verified peptide content or purity. Dosing from an unlabeled vial bought online is genuinely dangerous.

A weight loss injection obtained without a prescription, from an overseas vendor, or from an unverified online source is not the same product as what a licensed 503A pharmacy dispenses under a valid prescription. The legitimate pathway — intake, clinician review, licensed pharmacy — exists precisely because these medications require medical oversight.

FAQs: how to get a weight loss injection

How do you get a weight loss injection?

You need a prescription from a licensed clinician. The typical process is: complete an online health intake, have a clinician review your eligibility, receive a prescription if appropriate, and have the medication dispensed from a licensed 503A pharmacy. Telehealth platforms like PepScribe make this process available without an in-person visit in most US states.

What weight loss injections are available through clinician prescription?

Semaglutide and tirzepatide are the most commonly prescribed GLP-1 and dual GIP/GLP-1 receptor agonists for weight management. Both are available as compounded preparations from licensed 503A pharmacies under a clinician prescription.

Can you get weight loss injections online?

Yes. Licensed telehealth providers can issue valid prescriptions in most US states following an online clinical evaluation. The medication is then shipped from a licensed 503A compounding pharmacy directly to your address.

Do you need to be a certain weight to get a weight loss injection?

Prescribing guidelines for GLP-1 medications typically require a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnea. Your clinician makes the final determination based on your full health history.

How much do weight loss injections cost without insurance?

Branded GLP-1 medications can cost $1,000 or more per month without insurance. Compounded semaglutide and tirzepatide from licensed 503A pharmacies are generally available at substantially lower price points through telehealth platforms. Specific pricing varies by dose tier and provider.

Are weight loss injections safe?

Semaglutide and tirzepatide have been evaluated in large clinical trials and are FDA-approved as branded medications. The most common side effects are GI-related (nausea, vomiting, diarrhea), particularly during dose escalation. Serious side effects are less common but include pancreatitis and gallbladder disease. Clinicians screen for contraindications before prescribing.

References

  1. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial). New England Journal of Medicine (Wilding JPH, et al.) — PMID 33567185 (2021).
  2. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial). New England Journal of Medicine (Jastreboff AM, et al.) — PMID 35658024 (2022).
  3. FDA Approves New Drug Treatment for Chronic Weight Management. U.S. Food & Drug Administration — Drug Approvals and Databases (2021).

Start the intake. Talk to a clinician today.

Compounded in the USA by licensed 503A pharmacies. Clinician review within 24 hours. No hidden overseas supply chain.